Header cover image

Norwegian (OSEAX) Biotech Industry Analysis

UpdatedFeb 14, 2025
DataAggregated Company Financials
Companies11
  • 7D-2.2%
  • 3M23.3%
  • 1Y-56.9%
  • YTD1.8%

Over the last 7 days, the Biotech industry has remained flat, although notably Hofseth BioCare gained 7.8%. Unfortunately though, the industry is down 56% over the past 12 months. As for the next few years, earnings are expected to grow by 24% per annum.

Industry Valuation and Performance

Has the Norwegian Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 14 Feb 2025NOK 5.1bNOK 457.3m-NOK 1,122,407,354.72172.6x-4.5x11.2x
Sun, 12 Jan 2025NOK 4.6bNOK 458.1m-NOK 1,078,107,616.98157.4x-4.3x10.1x
Tue, 10 Dec 2024NOK 4.3bNOK 456.5m-NOK 1,064,255,412.26146.8x-4.1x9.5x
Thu, 07 Nov 2024NOK 4.1bNOK 472.9m-NOK 1,075,132,975.8048.2x-3.9x8.8x
Sat, 05 Oct 2024NOK 5.0bNOK 470.1m-NOK 1,059,165,831.8558.9x-4.7x10.7x
Mon, 02 Sep 2024NOK 6.0bNOK 471.3m-NOK 1,035,118,355.3066.3x-5.8x12.7x
Wed, 31 Jul 2024NOK 9.3bNOK 517.3m-NOK 1,054,492,149.6174.9x-8.8x17.9x
Fri, 28 Jun 2024NOK 9.1bNOK 642.0m-NOK 942,400,959.2137.4x-9.6x14.1x
Sun, 26 May 2024NOK 9.0bNOK 630.4m-NOK 976,448,522.3438.6x-9.2x14.3x
Tue, 23 Apr 2024NOK 8.6bNOK 660.3m-NOK 962,444,295.7437.4x-8.9x13x
Thu, 21 Mar 2024NOK 8.9bNOK 654.7m-NOK 934,223,461.6039.2x-9.6x13.6x
Sat, 17 Feb 2024NOK 15.1bNOK 671.9m-NOK 1,003,515,434.3037.4x-15.1x22.5x
Mon, 15 Jan 2024NOK 16.4bNOK 654.1m-NOK 1,352,223,251.0059.2x-12.1x25x
Wed, 13 Dec 2023NOK 15.2bNOK 664.1m-NOK 1,381,204,144.0058.5x-11x22.9x
Fri, 10 Nov 2023NOK 14.4bNOK 620.2m-NOK 1,471,136,123.0057.4x-9.8x23.2x
Sun, 08 Oct 2023NOK 14.6bNOK 627.1m-NOK 1,464,513,549.0049.6x-10x23.4x
Tue, 05 Sep 2023NOK 15.8bNOK 625.9m-NOK 1,425,212,068.0058.3x-11.1x25.2x
Thu, 03 Aug 2023NOK 15.9bNOK 556.5m-NOK 1,457,696,286.0055.8x-10.9x28.6x
Sat, 01 Jul 2023NOK 15.1bNOK 561.6m-NOK 1,478,500,076.0060.8x-10.2x27x
Mon, 29 May 2023NOK 17.1bNOK 564.4m-NOK 1,503,734,245.0063.8x-11.4x30.3x
Wed, 26 Apr 2023NOK 16.9bNOK 541.7m-NOK 1,445,458,420.0029.9x-11.7x31.3x
Fri, 24 Mar 2023NOK 15.2bNOK 535.7m-NOK 1,553,176,509.0029.6x-9.8x28.4x
Sun, 19 Feb 2023NOK 18.3bNOK 837.0m-NOK 1,434,693,996.0032.6x-12.7x21.8x
Tue, 17 Jan 2023NOK 18.4bNOK 808.8m-NOK 1,394,196,750.0024.7x-13.2x22.7x
Thu, 15 Dec 2022NOK 20.9bNOK 803.2m-NOK 1,391,200,712.0043x-15x26x
Sat, 12 Nov 2022NOK 18.7bNOK 792.3m-NOK 1,358,346,015.0036.2x-13.8x23.6x
Mon, 10 Oct 2022NOK 17.6bNOK 816.0m-NOK 1,365,481,897.0037.5x-12.9x21.6x
Wed, 07 Sep 2022NOK 19.7bNOK 791.6m-NOK 1,366,773,447.0036.8x-14.4x24.9x
Fri, 05 Aug 2022NOK 22.1bNOK 764.9m-NOK 1,379,723,545.0046.6x-16x28.9x
Sun, 03 Jul 2022NOK 19.5bNOK 773.1m-NOK 1,381,948,103.0043x-14.1x25.2x
Tue, 31 May 2022NOK 22.3bNOK 1.1b-NOK 1,030,235,367.0040.3x-21.6x20.6x
Thu, 28 Apr 2022NOK 23.1bNOK 1.1b-NOK 991,088,007.0040.2x-23.3x21.9x
Sat, 26 Mar 2022NOK 26.5bNOK 2.6bNOK 374.4m10x70.8x10.1x
Mon, 21 Feb 2022NOK 27.0bNOK 2.7bNOK 449.7m10.1x60.1x10x
Price to Earnings Ratio

60.1x


Total Market Cap: NOK 27.0bTotal Earnings: NOK 449.7mTotal Revenue: NOK 2.7bTotal Market Cap vs Earnings and Revenue0%0%0%
Norwegian Biotech Industry Price to Earnings3Y Average -8.1x202320242025
Current Industry PE
  • Investors are pessimistic on the Norwegian Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 20.5x is higher than the industry's current PS ratio of 11.3x.
Past Earnings Growth
  • Total earnings for the Biotechs industry have declined over the last three years, with the industry now making a loss overall.
  • Revenues have also declined 45% per year, which is driving profits down.

Industry Trends

Which industries have driven the changes within the Norwegian Healthcare industry?

NO Market-1.37%
Healthcare-1.08%
Biotech-2.17%
Biotech-2.17%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
AZT ArcticZymes TechnologiesNOK 19.0035.7%
+NOK 255.4m
-29.0%PE128.2x
PCIB PCI Biotech HoldingNOK 1.337.8%
+NOK 3.6m
-30.8%PS8.3x
ULTI UltimovacsNOK 2.100.5%
+NOK 344.1k
-98.5%PB0.9x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

AZT

NOK 19.00

ArcticZymes Technologies

7D

35.7%

1Y

-29.0%

ULTI

NOK 2.10

Ultimovacs

7D

0.5%

1Y

-98.5%

LYTIX

NOK 5.54

Lytix Biopharma

7D

-4.5%

1Y

-14.8%

TRMED

NOK 2.34

Thor Medical

7D

-6.6%

1Y

106.7%

EXTX

NOK 3.32

EXACT Therapeutics

7D

-9.3%

1Y

-69.3%

BGBIO

NOK 7.77

BerGenBio

7D

-4.0%

1Y

-65.1%

NYKD

NOK 2.42

Nykode Therapeutics

7D

-0.3%

1Y

-87.2%

CRNA

NOK 0.63

Circio Holding

7D

-1.9%

1Y

-90.0%

HBC

NOK 2.77

Hofseth BioCare

7D

-9.2%

1Y

15.4%

ABS

NOK 2.98

Arctic Bioscience

7D

-4.5%

1Y

-70.2%

PCIB

NOK 1.33

PCI Biotech Holding

7D

7.8%

1Y

-30.8%